Medical Journals

Cardiomyocyte-restricted Restoration of Nitric Oxide Synthase 3 Attenuates Left Ventricular Remodeling After Chronic Pressure Overload.

Authors:
  • Buys Emmanuel S
  • Raher Michael J
  • Blake Sarah L
  • Neilan Tomas G
  • Graveline Amanda R
  • Passeri Jonathan J
  • Llano Miguel
  • Perez-Sanz Teresa M
  • Ichinose Fumito
  • Janssens Stefan
  • Zapol Warren M
  • Picard Michael H
  • Bloch Kenneth D
  • Scherrer-Crosbie Marielle

From: Cardiac Ultrasound Laboratory, 55 Fruit Street, Boston, MA 02115-2696, USA.

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Jul 2007
  • ISSN: 0363-6135
  • Volume: 293
  • Issue: 1
  • Pages: H620-7
  • Medium: Print
  • Language: English
  • Citation (JAMA): Buys Emmanuel S, Raher Michael J, Blake Sarah L, et al. Cardiomyocyte-restricted Restoration of Nitric Oxide Synthase 3 Attenuates Left Ventricular Remodeling After Chronic Pressure Overload.. Am. J. Physiol. Heart Circ. Physiol. Jul 2007;293:H620-7

Abstract

Although nitric oxide synthase (NOS)3 is implicated as an important modulator of left ventricular (LV) remodeling, its role in the cardiac response to chronic pressure overload is controversial. We examined whether selective restoration of NOS3 to the hearts of NOS3-deficient mice would modulate the LV remodeling response to transverse aortic constriction (TAC). LV structure and function were compared at baseline and after TAC in NOS3-deficient (NOS3(-/-)) mice and NOS3(-/-) mice carrying a transgene directing NOS3 expression specifically in cardiomyocytes (NOS3(-/-TG) mice). At baseline, echocardiographic assessment of LV dimensions and function, invasive hemodynamic measurements, LV mass, and myocyte width did not differ between the two genotypes. Four weeks after TAC, echocardiographic and hemodynamic indexes of LV systolic function indicated that contractile performance was better preserved in NOS3(-/-TG) mice than in NOS3(-/-) mice. Echocardiographic LV wall thickness and cardiomyocyte width were greater in NOS3(-/-) mice than in NOS3(-/-TG) mice. TAC-induced cardiac fibrosis did not differ between these genotypes. TAC increased cardiac superoxide generation in NOS3(-/-TG) but not NOS3(-/-) mice. The ratio of NOS3 dimers to monomers did not differ before and after TAC in NOS3(-/-TG) mice. Restoration of NOS3 to the heart of NOS3-deficient mice attenuates LV hypertrophy and dysfunction after TAC, suggesting that NOS3 protects against the adverse LV remodeling induced by prolonged pressure overload.

Mesh Headings (Keywords): Animals, Cells, Cultured, Hypertension, Hypertrophy, Left Ventricular, Mice, Mice, Transgenic, Myocytes, Cardiac, Nitric Oxide Synthase Type II, Ventricular Dysfunction, Left, Ventricular Remodeling


Check for Full Text / PubMed Unique Identifier (PMID): 17416602


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.